Alaunos Therapeutics, Inc. Accounts Receivable, Allowance for Credit Loss, Current
Alaunos Therapeutics, Inc. (TCRT) had Accounts Receivable, Allowance for Credit Loss, Current of $322.00 thousand as of 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2016-05-10
- 2016-03-31: Accounts Receivable, Allowance for Credit Loss, Current $322.00K.
- 2015-12-31: Accounts Receivable, Allowance for Credit Loss, Current $0.00.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current |
|---|---|
| 2016-03-31 | $322.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $0.00 10-Q · filed 2016-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |